Novel Glucagon-like Peptide 1 Receptor Agonists for Treating Type II Diabetes.

Published in: ACS medicinal chemistry letters (2024)

Provided herein are novel glucagon-like peptide-1 receptor agonists, pharmaceutical compositions, use of such compounds in treating type II diabetes, and processes for preparing such compounds.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
metabolic syndrome
insulin resistance
weight loss